Answers are grounded in this paper and cite their sources.
Mesoporous silica nanoparticles show promise as a drug-carrier vehicle for biomedical applications, but the development of simple, biocompatible capping systems has remained a challenge. We have found that lysozyme molecules can act as a pH-responsive nanovalve to block and unlock the pore entrances of MCM-41 nanoparticles for guest molecules. Our experiments indicate that pore blocking is due to a pH-induced conformational change by which the effective size of the protein is changed in a reversible manner. This effect may form the basis of a controlled-release system without the need to functionalize the pore mouth and caps.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: